Apimeds Pharmaceuticals US, Inc. (APUS) KPIs and segments

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$2.23−0.04 (-1.76%)

Close on Nov 13, 2026Market cap $3.37MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Apimeds Pharmaceuticals US's business

Coming soon

This tab will track the numbers specific to Apimeds Pharmaceuticals US's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?